0

CGS-15943

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP104615181
CAS104615-18-1
Structure
MDL NumberMFCD01529897
Molecular Weight285.69
InChI KeyMSJODEOZODDVGW-UHFFFAOYSA-N
Descriptionsolid
SolubilityDMSO: >10 mg/mL; H2O: insoluble
Assay≥98% (HPLC)
Colorwhite
Formsolid
Size25MG
Storage Conditionsroom temp
1

Biochemical Characterization of the Triazoloquinazoline, CGS 15943, a Novel, Non-Xanthine Adenosine Antagonist

M Williams, J Francis, G Ghai, A Braunwalder, S Psychoyos, G A Stone, W D Cash

J Pharmacol Exp Ther. 1987 May;241(2):415-20.

PMID: 2883298

1

Caffeine and the Analog CGS 15943 Inhibit Cancer Cell Growth by Targeting the Phosphoinositide 3-kinase/Akt Pathway

Charlotte E Edling, Federico Selvaggi, Ragheda Ghonaim, Tania Maffucci, Marco Falasca

Cancer Biol Ther. 2014 May;15(5):524-32.

PMID: 24521981

1

CGS 15943, a Nonxanthine Adenosine Receptor Antagonist: Effects on Locomotor Activity of Nontolerant and Caffeine-Tolerant Rats

S G Holtzman

Life Sci. 1991;49(21):1563-70.

PMID: 1943461

1

Comparison of CGS 15943, ZM 241385 and SCH 58261 as Antagonists at Human Adenosine Receptors

E Ongini, S Dionisotti, S Gessi, E Irenius, B B Fredholm

Naunyn Schmiedebergs Arch Pharmacol. 1999 Jan;359(1):7-10.

PMID: 9933143

1

Influence of CGS 15943 A (A Nonxanthine Adenosine Antagonist) on the Protection Offered by a Variety of Antiepileptic Drugs Against Maximal Electroshock-Induced Seizures in Mice

S J Czuczwar, W Janusz, B Szczepanik, Z Kleinrok

J Neural Transm Gen Sect. 1991;86(2):127-34.

PMID: 1953988

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode